Pages without language links

Jump to navigation Jump to search

The following pages do not link to other language versions.

Showing below up to 50 results in range #109,751 to #109,800.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. The Forsyth Institute
  2. The Frankenfood Myth
  3. The Fred Hollows Foundation
  4. The GENESIS Trial Demonstrates Disappointing Results With Pimecrolimus Eluting Stents
  5. The GISSI-HF trial suggests long-term treatment with n-3 PUFAs provides moderate clinical benefits for chronic heart failure patients
  6. The GRACE risk score
  7. The George Foundation
  8. The George Institute for International Health
  9. The Global Fund to Fight AIDS, Tuberculosis and Malaria
  10. The Golden Book of Chemistry Experiments
  11. The Gothenburg Study of Children with DAMP
  12. The Grit
  13. The Group Selection Squad
  14. The Hacker's Diet
  15. The Heart in Insulin Dependent Diabetes Mellitus
  16. The Heart in Köhlmeier-Degos Disease
  17. The Heuga Center for Multiple Sclerosis
  18. The Homelessness Project
  19. The Hormone Foundation
  20. The Inner Life of the Cell
  21. The Instance of the Letter in the Unconscious, or Reason Since Freud
  22. The Institute for Genomic Research
  23. The Institute of Living
  24. The International Journal of Psychiatry
  25. The International Paleopsychology Project
  26. The International Society of Pharmacovigilance
  27. The Israel Journal of Psychiatry and Related Sciences
  28. The JUPITER Trial
  29. The Jimmy Fund
  30. The Journal of Medical Practice Management
  31. The Kurtzke Expanded Disability Status Scale (EDSS)
  32. The Lancet
  33. The Leaf (AI) Project
  34. The Learning Center for Deaf Children
  35. The Living Guidelines:UA/NSTEMI Antiplatelet Therapy
  36. The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI Polling Results for CLASS III Guidelines
  37. The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI Polling Results for CLASS I Guidelines
  38. The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI Suggest Revisions to the CLASS III Guidelines
  39. The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI Suggest Revisions to the CLASS I Guidelines
  40. The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI View the Current CLASS III Guidelines
  41. The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI View the Current CLASS I Guidelines
  42. The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin Polling Results for CLASS IIa Guidelines
  43. The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin Polling Results for CLASS I Guidelines
  44. The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin Suggest Revisions to the CLASS IIa Guidelines
  45. The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin Suggest Revisions to the CLASS I Guidelines
  46. The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin View the Current CLASS IIa Guidelines
  47. The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin View the Current CLASS I Guidelines
  48. The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel Polling Results for CLASS IIa Guidelines
  49. The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel Polling Results for CLASS I Guidelines
  50. The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel Suggest Revisions to the CLASS IIa Guidelines

View ( | ) (20 | 50 | 100 | 250 | 500)